DGX

QUEST DIAGNOSTICS INC

SEC CIK 1022079
$195.00 −4.6% · 90 days
90-day buys
$0
0 open-market
90-day sells
$3.57M
2 open-market
Net insider flow
−$3.57M
Net selling
Filings shown
183
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at DGX have sold a net $3.57M of stock (0 open-market buys vs 2 sells).

Largest recent trade: Rusckowski Stephen H sold $35.04M of DGX, trimming their stake 55%.

Most active filer: Doherty Catherine T., with 44 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for DGX, newest first
View on SEC EDGAR ↗
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Dec 1, 2021 ΔOwn −17%

Doherty Catherine T. sold $2.3M of DGX, trimming their stake 17%.

−$2.3M
14,575 sh @ $158
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Jul 30, 2021 ΔOwn −1.8%

Rusckowski Stephen H sold $745.1K of DGX, trimming their stake 2%.

−$745.1K
5,300 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Jul 30, 2021 ΔOwn −1.5%

Rusckowski Stephen H sold $592.1K of DGX, trimming their stake 1%.

−$592.1K
4,193 sh @ $141
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Jul 30, 2021 ΔOwn −33%

Rusckowski Stephen H sold $19.58M of DGX, trimming their stake 33%.

−$19.58M
139,751 sh @ $140
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Jul 28, 2021 ΔOwn −10%

Rusckowski Stephen H sold $4.59M of DGX, trimming their stake 10%.

−$4.59M
32,788 sh @ $140
Advertisement
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Jul 28, 2021 ΔOwn −2.0%

Rusckowski Stephen H sold $814K of DGX, trimming their stake 2%.

−$814K
5,813 sh @ $140
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed May 11, 2021 ΔOwn −11%

Doherty Catherine T. sold $1.19M of DGX, trimming their stake 11%.

−$1.19M
8,536 sh @ $140
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed May 7, 2021 ΔOwn −53%

Prevoznik Michael E sold $6.16M of DGX, trimming their stake 53%.

−$6.16M
44,939 sh @ $137
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 11, 2021 ΔOwn −12%

Prevoznik Michael E sold $671.5K of DGX, trimming their stake 12%.

−$671.5K
5,574 sh @ $120
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 1, 2021 ΔOwn −2.0%

Prevoznik Michael E sold $92.5K of DGX, trimming their stake 2%.

−$92.5K
801 sh @ $115
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 25, 2021 ΔOwn −1.0%

Prevoznik Michael E sold $51.2K of DGX, trimming their stake 1%.

−$51.2K
438 sh @ $117
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Feb 25, 2021 ΔOwn −1.8%

Prevoznik Michael E sold $87.7K of DGX, trimming their stake 2%.

−$87.7K
750 sh @ $117
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Oct 19, 2020 ΔOwn −55%

Rusckowski Stephen H sold $35.04M of DGX, trimming their stake 55%.

−$35.04M
291,997 sh @ $120
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Oct 15, 2020 ΔOwn −47%

Prevoznik Michael E sold $4.24M of DGX, trimming their stake 47%.

−$4.24M
35,591 sh @ $119
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Sep 4, 2020 ΔOwn −43%

Doherty Catherine T. sold $6.04M of DGX, trimming their stake 43%.

−$6.04M
54,616 sh @ $111
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Sep 4, 2020 ΔOwn −5.2%

Doherty Catherine T. sold $419.6K of DGX, trimming their stake 5%.

−$419.6K
3,776 sh @ $111
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Apr 28, 2020 ΔOwn −4.7%

Rusckowski Stephen H sold $1.31M of DGX, trimming their stake 5%.

−$1.31M
11,717 sh @ $112
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −0.5%

Davis J. E. sold $17.1K of DGX.

−$17.1K
200 sh @ $86
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −2.6%

Davis J. E. sold $94K of DGX, trimming their stake 3%.

−$94K
1,085 sh @ $87
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −3.2%

Davis J. E. sold $114.8K of DGX, trimming their stake 3%.

−$114.8K
1,307 sh @ $88
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −1.1%

Davis J. E. sold $37.3K of DGX, trimming their stake 1%.

−$37.3K
421 sh @ $89
DGX
Sell Davis J. E. · EVP, General Diagnostics · Open-market sale · filed Mar 17, 2020 ΔOwn −1.3%

Davis J. E. sold $45.1K of DGX, trimming their stake 1%.

−$45.1K
500 sh @ $90
DGX
Sell PREVOZNIK MICHAEL E · SVP & General Counsel · Open-market sale · filed Mar 12, 2020 ΔOwn −5.1%

Prevoznik Michael E sold $226.7K of DGX, trimming their stake 5%.

−$226.7K
2,175 sh @ $104
DGX
Sell Doherty Catherine T. · SVP, Group Exec. Clin. Fran. · Open-market sale · filed Mar 12, 2020 ΔOwn −3.5%

Doherty Catherine T. sold $260.7K of DGX, trimming their stake 4%.

−$260.7K
2,501 sh @ $104
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Mar 10, 2020 ΔOwn −37%

Rusckowski Stephen H sold $19.19M of DGX, trimming their stake 37%.

−$19.19M
171,025 sh @ $112
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Mar 10, 2020 ΔOwn −13%

Rusckowski Stephen H sold $4.18M of DGX, trimming their stake 13%.

−$4.18M
36,790 sh @ $114
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Mar 10, 2020 ΔOwn −6.6%

Rusckowski Stephen H sold $1.88M of DGX, trimming their stake 7%.

−$1.88M
16,426 sh @ $114
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Mar 10, 2020 ΔOwn −1.7%

Rusckowski Stephen H sold $454.5K of DGX, trimming their stake 2%.

−$454.5K
3,937 sh @ $115
DGX
Sell RUSCKOWSKI STEPHEN H · Director, Chairman, CEO and President · Open-market sale · filed Mar 10, 2020 ΔOwn −0.9%

Rusckowski Stephen H sold $232.5K of DGX, trimming their stake 1%.

−$232.5K
2,000 sh @ $116
Advertisement

About DGX insider activity

This page tracks every recent Form 4 filed for QUEST DIAGNOSTICS INC with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is DGX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for QUEST DIAGNOSTICS INC usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.